Abstract:Significance The Pictet–Spengler (PS) reaction constructs many important phytochemicals such as morphine and camptothecin, but it has not yet been noticed in the fungal kingdom. Here, the startup of the PS reaction-based silent fungal biosynthetic machinery is presented to generate unforeseeably “unnatural” natural products of unprecedented carbon skeletons with antibacterial and acetylcholinesterase inhibitory activities. The gene-implied enzyme inhibition strategy is introduced to facilitate understandings of the key diversification steps. Collectively, the PS reaction-based fungal biosynthetic machinery that used to be silent has been set up to produce unpredictably novel molecules valuable for new biology and biomedicine. The Pictet–Spengler (PS) reaction constructs plant alkaloids such as morphine and camptothecin, but it has not yet been noticed in the fungal kingdom. Here, a silent fungal Pictet–Spenglerase (FPS) gene of Chaetomium globosum 1C51 residing in Epinephelus drummondhayi guts is described and ascertained to be activable by 1-methyl-l-tryptophan (1-MT). The activated FPS expression enables the PS reaction between 1-MT and flavipin (fungal aldehyde) to form “unnatural” natural products with unprecedented skeletons, of which chaetoglines B and F are potently antibacterial with the latter inhibiting acetylcholinesterase. A gene-implied enzyme inhibition (GIEI) strategy has been introduced to address the key steps for PS product diversifications. In aggregation, the work designs and validates an innovative approach that can activate the PS reaction-based fungal biosynthetic machinery to produce unpredictable compounds of unusual and novel structure valuable for new biology and biomedicine.

Biosynthesis mechanism, genome mining and artificial construction of echinocandin O-sulfonation

Biochemical and molecular analysis of the biosynthesis of fumonisins

Analysis of FR901379 Biosynthetic Genes in Coleophoma empetri by Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Based Genomic Manipulation

Analysis of FR901379 Biosynthetic Genes in <i>Coleophoma empetri</i> by Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Based Genomic Manipulation

Unnatural Tetradeoxy Echinocandins Produced by Gene Cluster Design and Heterologous Expression.

Aminoacyl sulfonamide assembly in SB-203208 biosynthesis.

Complex Interplay and Catalytic Versatility of Tailoring Enzymes for Efficient and Selective Biosynthesis of Fungal Mycotoxins

Biosynthetic Engineering of the Antifungal, Anti-Mrsa Auroramycin

Multiplex Base-Editing Enables Combinatorial Epigenetic Regulation for Genome Mining of Fungal Natural Products.

Engineering fungal secondary metabolism: a roadmap to novel compounds.

Structural Basis of Nonribosomal Peptide Macrocyclization in Fungi

Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1

A Hadal Streptomyces-Derived Echinocandin Acylase Discovered through the Prioritization of Protein Families

Advances in Chemical Epigenetic Modification Methods in the Study of Fungal Secondary Metabolites

Biosynthetic characterization and combinatorial biocatalysis of the cysteine protease inhibitor E-64

Application of acylases in the production of echinocandin antifungals

Pictet–Spengler Reaction-Based Biosynthetic Machinery in Fungi

A target and efficient synthetic strategy for structural and bioactivity optimization of a fungal natural product

Epigenetic Genome Mining of an Endophytic Fungus Leads to the Pleiotropic Biosynthesis of Natural Products

Biosynthesis of the Anti-infective Marformycins Featuring Pre-NRPS Assembly Line N-Formylation and O-Methylation and Post-Assembly Line C-Hydroxylation Chemistries

Unprecedented [5.5.5.6]Dioxafenestrane Ring Construction in Fungal Insecticidal Sesquiterpene Biosynthesis